Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America

Autores
Condino Neto, A.; Costa Carvalho, B. T.; Grumach, A. S.; King, A.; Bezrodnik, Liliana; Oleastro, M.; Leiva, L.; Porras, O.; Espinosa Rosales, F. J.; Franco, J. L.; Sorensen, R. U.
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.
Fil: Condino Neto, A.. Universidade de Sao Paulo; Brasil
Fil: Costa Carvalho, B. T.. Universidade Federal de Sao Paulo; Brasil
Fil: Grumach, A. S.. No especifíca;
Fil: King, A.. No especifíca;
Fil: Bezrodnik, Liliana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Área de Inmunología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Oleastro, M.. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Leiva, L.. Louisiana Tech University; Estados Unidos
Fil: Porras, O.. Hospital Nacional de Ninos ˜ Dr Carlos Sáenz Herrera"; Costa Rica
Fil: Espinosa Rosales, F. J.. Instituto Nacional de Pediatría; México
Fil: Franco, J. L.. Universidad de Antioquia; Colombia
Fil: Sorensen, R. U.. Universidad de La Frontera; Chile
Materia
GUIDELINES
IMMUNOGLOBULIN REPLACEMENT THERAPY
INTRAVENOUS IMMUNOGLOBULIN
LATIN AMERICA
PRIMARY IMMUNODEFICIENCY
SUBCUTANEOUS IMMUNOGLOBULIN
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/197433
Acceder
id CONICETDig_1c3ea2c54f0765394c8ecce9ce4dabaf
oai_identifier_str oai:ri.conicet.gov.ar:11336/197433
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin AmericaCondino Neto, A.Costa Carvalho, B. T.Grumach, A. S.King, A.Bezrodnik, LilianaOleastro, M.Leiva, L.Porras, O.Espinosa Rosales, F. J.Franco, J. L.Sorensen, R. U.GUIDELINESIMMUNOGLOBULIN REPLACEMENT THERAPYINTRAVENOUS IMMUNOGLOBULINLATIN AMERICAPRIMARY IMMUNODEFICIENCYSUBCUTANEOUS IMMUNOGLOBULINhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.Fil: Condino Neto, A.. Universidade de Sao Paulo; BrasilFil: Costa Carvalho, B. T.. Universidade Federal de Sao Paulo; BrasilFil: Grumach, A. S.. No especifíca;Fil: King, A.. No especifíca;Fil: Bezrodnik, Liliana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Área de Inmunología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Oleastro, M.. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Leiva, L.. Louisiana Tech University; Estados UnidosFil: Porras, O.. Hospital Nacional de Ninos ˜ Dr Carlos Sáenz Herrera"; Costa RicaFil: Espinosa Rosales, F. J.. Instituto Nacional de Pediatría; MéxicoFil: Franco, J. L.. Universidad de Antioquia; ColombiaFil: Sorensen, R. U.. Universidad de La Frontera; ChileElsevier Doyma Sl2012-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/197433Condino Neto, A.; Costa Carvalho, B. T.; Grumach, A. S.; King, A.; Bezrodnik, Liliana; et al.; Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America; Elsevier Doyma Sl; Allergologia Et Immunopathologia.; 42; 3; 9-2012; 245-2600301-0546CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-articulo-guidelines-for-use-human-immunoglobulin-S0301054612002984info:eu-repo/semantics/altIdentifier/doi/10.1016/j.aller.2012.09.006info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:31:33Zoai:ri.conicet.gov.ar:11336/197433instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:31:33.452CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
spellingShingle Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
Condino Neto, A.
GUIDELINES
IMMUNOGLOBULIN REPLACEMENT THERAPY
INTRAVENOUS IMMUNOGLOBULIN
LATIN AMERICA
PRIMARY IMMUNODEFICIENCY
SUBCUTANEOUS IMMUNOGLOBULIN
title_short Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_full Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_fullStr Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_full_unstemmed Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
title_sort Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
dc.creator.none.fl_str_mv Condino Neto, A.
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, Liliana
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco, J. L.
Sorensen, R. U.
author Condino Neto, A.
author_facet Condino Neto, A.
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, Liliana
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco, J. L.
Sorensen, R. U.
author_role author
author2 Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, Liliana
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco, J. L.
Sorensen, R. U.
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv GUIDELINES
IMMUNOGLOBULIN REPLACEMENT THERAPY
INTRAVENOUS IMMUNOGLOBULIN
LATIN AMERICA
PRIMARY IMMUNODEFICIENCY
SUBCUTANEOUS IMMUNOGLOBULIN
topic GUIDELINES
IMMUNOGLOBULIN REPLACEMENT THERAPY
INTRAVENOUS IMMUNOGLOBULIN
LATIN AMERICA
PRIMARY IMMUNODEFICIENCY
SUBCUTANEOUS IMMUNOGLOBULIN
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.
Fil: Condino Neto, A.. Universidade de Sao Paulo; Brasil
Fil: Costa Carvalho, B. T.. Universidade Federal de Sao Paulo; Brasil
Fil: Grumach, A. S.. No especifíca;
Fil: King, A.. No especifíca;
Fil: Bezrodnik, Liliana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Área de Inmunología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Oleastro, M.. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Leiva, L.. Louisiana Tech University; Estados Unidos
Fil: Porras, O.. Hospital Nacional de Ninos ˜ Dr Carlos Sáenz Herrera"; Costa Rica
Fil: Espinosa Rosales, F. J.. Instituto Nacional de Pediatría; México
Fil: Franco, J. L.. Universidad de Antioquia; Colombia
Fil: Sorensen, R. U.. Universidad de La Frontera; Chile
description Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.
publishDate 2012
dc.date.none.fl_str_mv 2012-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/197433
Condino Neto, A.; Costa Carvalho, B. T.; Grumach, A. S.; King, A.; Bezrodnik, Liliana; et al.; Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America; Elsevier Doyma Sl; Allergologia Et Immunopathologia.; 42; 3; 9-2012; 245-260
0301-0546
CONICET Digital
CONICET
url http://hdl.handle.net/11336/197433
identifier_str_mv Condino Neto, A.; Costa Carvalho, B. T.; Grumach, A. S.; King, A.; Bezrodnik, Liliana; et al.; Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America; Elsevier Doyma Sl; Allergologia Et Immunopathologia.; 42; 3; 9-2012; 245-260
0301-0546
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-articulo-guidelines-for-use-human-immunoglobulin-S0301054612002984
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.aller.2012.09.006
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Doyma Sl
publisher.none.fl_str_mv Elsevier Doyma Sl
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083450974502912
score 13.221938

Publicaciones similares